Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.43 |
| ▸ | ANPEP | P15144 | 7/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 4/20 | 0.41 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.41 |
| ▸ | LAP3 | P28838 | 4/20 | 0.38 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.36 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.35 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.34 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16017830 | 0.94 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL31672568 | 0.89 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL13144609 | 0.86 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL9506655 | 0.84 | SLC7A5 (0.45) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL9621432 | 0.84 | SLC7A5 (0.45) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL9506659 | 0.84 | SLC7A5 (0.45) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL10403593 | 0.84 | SLC7A5 (0.54) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL133092 | 0.84 | SLC7A5 (0.54) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL7359844 | 0.84 | SLC7A5 (0.54) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL10403594 | 0.84 | SLC7A5 (0.54) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9056155-B1 | Coatings having an elastic primer layer | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2015-06-16 | — | — | US | disclosed |
| US-8865189-B2 | Poly(ester amide)-based drug delivery systems | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-10-21 | — | — | US | disclosed |
| US-20130129794-A1 | Poly(Ester Amide)-Based Drug Delivery Systems | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2013-05-23 | — | — | US | disclosed |
| US-8389044-B2 | Poly(ester amide)-based drug delivery systems with controlled release rate and morphology | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2013-03-05 | — | — | US | disclosed |
| US-8377499-B2 | Methods of forming Poly(ester amide)-based drug delivery systems with controlled release rate and morphology | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2013-02-19 | — | — | US | disclosed |
| US-8377107-B2 | Poly(ester amide)-based drug delivery systems with controlled release rate and morphology | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2013-02-19 | — | — | US | disclosed |
| US-20110200660-A1 | POLY(ESTER AMIDE)-BASED DRUG DELIVERY SYSTEMS WITH CONTROLLED RELEASE RATE AND MORPHOLOGY | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2011-08-18 | — | — | US | disclosed |
| US-20110151104-A1 | POLY(ESTER AMIDE)-BASED DRUG DELIVERY SYSTEMS WITH CONTROLLED RELEASE RATE AND MORPHOLOGY | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-7910152-B2 | Poly(ester amide)-based drug delivery systems with controlled release rate and morphology | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2011-03-22 | — | — | US | disclosed |
| US-7749263-B2 | Poly(ester amide) filler blends for modulation of coating properties | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2010-07-06 | — | — | US | disclosed |
| US-20080206306-A1 | POLY(ESTER AMIDE) BLOCK COPOLYMERS | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2008-08-28 | — | — | US | disclosed |
| US-20080175886-A1 | Blends Of Poly(Ester Amide) Polymers | ADVANCED CARDIOVASCULAR SYSTEM INC. (US) | 2008-07-24 | — | — | US | disclosed |
| US-20080177008-A1 | Blends Of Poly(Ester Amide) Polymers | ADVANCED CARDIOVASCULAR SYSTEMS INC. (US) | 2008-07-24 | — | — | US | disclosed |
| US-20080167712-A1 | POLY(ESTER AMIDE) FILLER BLENDS FOR MODULATION OF COATING PROPERTIES | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2008-07-10 | — | — | US | disclosed |
| US-7390497-B2 | Poly(ester amide) filler blends for modulation of coating properties | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2008-06-24 | — | — | US | disclosed |
| US-7365133-B2 | Blends of poly(ester amide) polymers | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2008-04-29 | — | — | US | disclosed |
| US-20080095918-A1 | Coating construct with enhanced interfacial compatibility | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2008-04-24 | — | — | US | disclosed |
| US-20070202147-A1 | Poly(ester amide)-based drug delivery systems with controlled release rate and morphology | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2007-08-30 | — | — | US | disclosed |
| US-20070135909-A1 | Adhesion polymers to improve stent retention | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-06-14 | — | — | US | disclosed |
| US-20070093617-A1 | Blends of poly(ester amide) polymers | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110200660-A1 | POLY(ESTER AMIDE)-BASED DRUG DELIVERY SYSTEMS WITH CONTROLLED RELEASE RATE AND MORPHOLOGY | PAM, PUF60, ACMSD | SLC7A5 2035/4885SLC1A3 991/4885SLC1A2 1035/4885 |
| US-20080177008-A1 | Blends Of Poly(Ester Amide) Polymers | TAAR5, TAAR1, PAM | SLC7A5 4046/4885SLC1A3 4562/4885SLC1A2 4637/4885 |
| US-20080175886-A1 | Blends Of Poly(Ester Amide) Polymers | BMP2, NAAA, PHOSPHO1 | SLC7A5 4140/4885SLC1A3 2249/4885SLC1A2 2417/4885 |
| US-20070202147-A1 | Poly(ester amide)-based drug delivery systems with controlled release rate and morphology | PUF60, PAM, ACMSD | SLC7A5 1557/4885SLC1A3 662/4885SLC1A2 667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.